Reduced CTLA4 expression on tumor-infiltrating T cells might permit increased expression of CD80/CD86 on Hodgkin-Reed-Sternberg cells, thereby increasing T cell proliferation and modifying the tumor environment. The gene discussed is CD80; the disease is neoplasm.